Objective: The aim of the study was to evaluate the possible effects of calyceal choice for renal puncture under sonographic guidance on the outcomes of percutaneous nephrolithotomy (PNL). Materials and Methods: A total of 70 patients for whom ultrasound-guided PNL was planned for 20–30-mm single renal pelvic stones were prospectively allocated to group 1 (n:35) with middle calyx entry or group 2 (n:35) with lower calyx entry. Procedure-related parameters such as duration of operation, stone-free rates, complication rates, and radiation exposure time were analyzed in detail. Results: The mean age of the patients was 45.67 ± 1.50 years and the mean stone size was 316.4 ± 17.95 mm2. There was no significant difference regarding the age, BMI, stone burden, and the grade of hydronephrosis between the groups. Skin to collecting system distance was significantly shorter in the middle calyx entrance (p = 0.021). Total duration of the procedure was again significantly shorter in group 1 cases (74.69 ± 2.94 min) than in group 2 (84.29 ± 4.25 min) (p = 0.003). Regarding the success rates, the postoperative stone-free rate was higher in group 1 (91.4% in group 1, 80.0% in group 2, p = 0.305). Last, there was no statistically significant difference in hemoglobin reduction rates, blood transfusion requirements, and complication rates between the 2 groups. Conclusion: Getting access to the renal pelvis through the middle calyx during ultrasonic guided PNL procedure is more advantageous to lower the calyceal approach by reducing both the duration of the PNL procedure with significantly higher stone-free and comparable complication rates.

1.
Fernström
I
,
Johansson
B
.
Percutaneous pyelolithotomy. A new extraction technique
.
Scand J Urol Nephrol
.
1976
;
10
(
3
):
257
9
.
2.
Tanriverdi
O
,
Boylu
U
,
Kendirci
M
,
Kadihasanoglu
M
,
Horasanli
K
,
Miroglu
C
.
The learning curve in the training of percutaneous nephrolithotomy
.
Eur Urol
.
2007 Jul
;
52
(
1
):
206
11
.
3.
Türk
C
,
Petřík
A
,
Sarica
K
,
Seitz
C
,
Skolarikos
A
,
Straub
M
, et al.
EAU guidelines on interventional treatment for urolithiasis
.
Eur Urol
.
2016 Mar
;
69
(
3
):
475
82
.
4.
Kim
SC
,
Kuo
RL
,
Lingeman
JE
.
Percutaneous nephrolithotomy: an update
.
Curr Opin Urol
.
2003 May
;
13
(
3
):
235
41
.
5.
de la Rosette
J
,
Assimos
D
,
Desai
M
,
Gutierrez
J
,
Lingeman
J
,
Scarpa
R
, et al.
The clinical research office of the endourological society percutaneous nephrolithotomy global study: indications, complications, and outcomes in 5,803 patients
.
J Endourol
.
2011 Jan
;
25
(
1
):
11
7
.
6.
Basiri
A
,
Tabibi
A
,
Nouralizadeh
A
,
Arab
D
,
Rezaeetalab
GH
,
Hosseini Sharifi
SH
, et al.
Comparison of safety and efficacy of laparoscopic pyelolithotomy versus percutaneous nephrolithotomy in patients with renal pelvic stones: a randomized clinical trial
.
Urol J
.
2014 Nov 30
;
11
(
6
):
1932
7
.
7.
Michel
MS
,
Trojan
L
,
Rassweiler
JJ
.
Complications in percutaneous nephrolithotomy
.
Eur Urol
.
2007 Apr
;
51
(
4
):
899
906
.
8.
Tefekli
A
,
Ali Karadag
M
,
Tepeler
K
,
Sari
E
,
Berberoglu
Y
,
Baykal
M
, et al.
Classification of percutaneous nephrolithotomy complications using the modified clavien grading system: looking for a standard
.
Eur Urol
.
2008 Jan
;
53
(
1
):
184
90
.
9.
Mousavi-Bahar
SH
,
Mehrabi
S
,
Moslemi
MK
.
Percutaneous nephrolithotomy complications in 671 consecutive patients: a single-center experience
.
Urol J
.
2011 Fall
;
8
(
4
):
271
6
.
10.
Basiri
A
,
Ziaee
AM
,
Kianian
HR
,
Mehrabi
S
,
Karami
H
,
Moghaddam
SM
.
Ultrasonographic versus fluoroscopic access for percutaneous nephrolithotomy: a randomized clinical trial
.
J Endourol
.
2008 Feb
;
22
(
2
):
281
4
.
11.
Basiri
A
,
Kashi
AH
,
Zeinali
M
,
Nasiri
M
,
Sarhangnejad
R
,
Valipour
R
.
Ultrasound - guided access during percutaneous nephrolithotomy: entering desired calyx with appropriate entry site and angle
.
Int Braz J Urol
.
2016 Nov-Dec
;
42
(
6
):
1160
7
.
12.
Liu
Q
,
Zhou
L
,
Cai
X
,
Jin
T
,
Wang
K
.
Fluoroscopy versus ultrasound for image guidance during percutaneous nephrolithotomy: a systematic review and meta-analysis
.
Urolithiasis
.
2017 Oct
;
45
(
5
):
481
7
.
13.
Agarwal
M
,
Agrawal
MS
,
Jaiswal
A
,
Kumar
D
,
Yadav
H
,
Lavania
P
.
Safety and efficacy of ultrasonography as an adjunct to fluoroscopy for renal access in percutaneous nephrolithotomy (PCNL)
.
BJU Int
.
2011 Oct
;
108
(
8
):
1346
9
.
14.
Andonian
S
,
Scoffone
CM
,
Louie
MK
,
Gross
AJ
,
Grabe
M
,
Daels
FP
, et al.
Does imaging modality used for percutaneous renal access make a difference? A matched case analysis
.
J Endourol
.
2013 Jan
;
27
(
1
):
24
8
.
15.
Tefekli
A
,
Esen
T
,
Olbert
PJ
,
Tolley
D
,
Nadler
RB
,
Sun
YH
, et al.
Isolated upper pole access in percutaneous nephrolithotomy: a large-scale analysis from the CROES percutaneous nephrolithotomy global study
.
J Urol
.
2013 Feb
;
189
(
2
):
568
73
.
16.
Caglayan
V
,
Onen
E
,
Avci
S
,
Kilic
M
,
Sambel
M
,
Oner
S
.
Percutaneous nephrolithotomy via a middle calyx access is effective in the treatment of lower pole kidney stones: a single-center study
.
Urol Int
.
2020 Jan 21
:
1
5
.
17.
Song
Y
,
Jin
W
,
Hua
S
,
Fei
X
.
Middle calyx access is better for single renal pelvic stone in ultrasound-guided percutaneous nephrolithotomy
.
Urolithiasis
.
2016 Oct
;
44
(
5
):
459
63
.
18.
Falahatkar
S
,
Kazemnezhad
E
,
Moghaddam
KG
,
Kazemzadeh
M
,
Asadollahzade
A
,
Farzan
A
, et al.
Middle calyx access in complete supine percutaneous nephrolithotomy
.
Can Urol Assoc J
.
2013 May-Jun
;
7
(
5–6
):
E306
10
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.